NEKTAR THERAPEUTICS Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Nektar Therapeutics quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Nektar Therapeutics Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.42M, a 32% decline year-over-year.
  • Nektar Therapeutics Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $26.8M, a 38% decline year-over-year.
  • Nektar Therapeutics annual Share-based Payment Arrangement, Expense for 2023 was $33.4M, a 41.8% decline from 2022.
  • Nektar Therapeutics annual Share-based Payment Arrangement, Expense for 2022 was $57.3M, a 39.5% decline from 2021.
  • Nektar Therapeutics annual Share-based Payment Arrangement, Expense for 2021 was $94.7M, a 0.44% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $33.4M -$23.9M -41.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $57.3M -$37.4M -39.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $94.7M +$413K +0.44% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $94.3M -$5.53M -5.55% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $99.8M +$11.7M +13.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $88.1M +$51.5M +141% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $36.6M +$10.8M +41.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $25.9M +$6.18M +31.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $19.7M +$2.65M +15.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $17M -$691K -3.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $17.7M +$1.51M +9.32% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
2012 $16.2M -$2.69M -14.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 $18.9M +$1.49M +8.54% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-01
2010 $17.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.